newsfilter
← Latest News
Business Wire·

Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit

New capabilities connect AI agents, scientific literature, and validated computational engines to accelerate model-informed drug development Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the